Valeant Can't Dodge Insider Trading Row Over Allergan Bid
A California federal judge on Monday refused to dismiss an insider trading lawsuit brought by two pension funds claiming Valeant Pharmaceuticals International Inc. illegally fed Pershing Square Capital Management LP inside...To view the full article, register now.
Already a subscriber? Click here to view full article